Risk factors for MDRD‐GFR of less than 60 mL/min per 1.73 m<sup>2</sup> in former kidney donors
Jang Han Lee(Ulsan College), Duck Jong Han(Asan Medical Center), Jai Won Chang, Song Cheol Kim(Ulsan College), Soon Bae Kim(Ulsan College), Jung Sik Park, Sang Koo Lee(Biotechnology Research Institute), Won Seok Yang, Su Kil Park
Cited by 26
Related Papers
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
|JNCI Journal of the National Cancer Institute|2019|299
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
|Journal of Controlled Release|2016|260